colorectal lesion
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who underwent colonoscopy at Showa University Northern Yokohama Hospital from October 2018 to January 2019. 2. Patients at the age of 18 years of age or older. 3. Patients who have no indication of denial about the use of data.
Exclusion criteria
Exclusion criteria: 1. Inflammatory bowel disease 2. Hereditary polyposis(e.g. FAP) 3. Patients who are judged ineligible at the discretion of the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To clarify whether the sensitivity of EB-00 for colorectal polyps exceeds 90%. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The specificity, PPV and NPV of EB-00. 2. The sensitivity, specificity, PPV and NPV for diminutive( <5mm) polyps. 3. The false positive rate of EB-00 4. The sensitivity, specificity, PPV and NPV for flat or depressed lesions. 5. The sensitivity, specificity, PPV and NPV for protruded lesions. | — |
Countries
Japan
Contacts
Showa University Northern Yokohama Hospital Digestive Disease Center